Preliminary studies: differences in microRNA expression in asthma and chronic obstructive pulmonary disease

Małgorzata Pietrusińska1, Aneta Pająk1, Paweł Górski1

  • 1Department of Pneumology and Allergology, Institute of Onternal Medicine, Medical University of Lodz, Lodz, Poland.

Abstract

Insights

Specific microRNAs (miRNAs) show altered expression in the blood serum of patients with asthma and chronic obstructive pulmonary disease (COPD). These findings suggest miRNAs play a role in the pathogenesis of these inflammatory lung diseases.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Genetics

Background:

  • Increasing global morbidity associated with asthma and chronic obstructive pulmonary disease (COPD).
  • Both asthma and COPD are characterized by inflammatory processes.
  • Emerging research highlights the role of microRNAs (miRNAs) in the pathogenesis of pulmonary diseases.

Purpose of the Study:

  • To investigate and compare the expression levels of specific miRNAs in the blood sera of patients diagnosed with bronchial asthma and COPD.
  • To establish a comparison between patient groups and healthy control subjects.

Main Methods:

  • Preliminary analysis comparing miRNA expression profiles in serum samples.
  • Inclusion of patient groups diagnosed with asthma and COPD.
  • Comparison with a control group of healthy individuals.

Main Results:

  • Significant differences in the expression of hsa-miRNA-224, hsa-miRNA-339-5p, and hsa-miRNA-382 were observed.
  • These expression differences were noted when comparing patients with asthma and COPD to healthy controls.

Conclusions:

  • The observed differential expression of specific miRNAs in serum suggests their significant involvement in the pathways of asthma and COPD.
  • Further studies with larger and more differentiated patient cohorts are warranted to elucidate the precise role of these miRNAs.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K